| 1 | 1611683 | Identification of the carboxymethyllysine residue in the advanced stage of glycated human serum albumin. | Chem Pharm Bull (Tokyo) | 1992 Mar |
1 |
| 2 | 8887292 | Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis. | Kidney Int | 1996 Oct |
3 |
| 3 | 9129235 | Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. | J Invest Dermatol | 1997 May |
1 |
| 4 | 9559679 | Conversion of Amadori product of Maillard reaction to Nepsilon-(carboxymethyl)lysine in alkaline condition. | FEBS Lett | 1998 Mar 27 |
4 |
| 5 | 9650745 | Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain. | Acta Neuropathol | 1998 Jun |
1 |
| 6 | 9767556 | N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis. | Kidney Int | 1998 Oct |
1 |
| 7 | 9782569 | Genesis of the uraemic syndrome: role of uraemic toxins. | Wien Klin Wochenschr | 1998 Aug 21 |
1 |
| 8 | 9846896 | Chemical modification of proteins by methylglyoxal. | Cell Mol Biol (Noisy-le-grand) | 1998 Nov |
1 |
| 9 | 10393704 | The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. | J Clin Invest | 1999 Jul |
3 |
| 10 | 10440132 | Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. | Diabetologia | 1999 Jul |
2 |
| 11 | 10531386 | N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. | J Biol Chem | 1999 Oct 29 |
2 |
| 12 | 10969841 | Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. | Diabetes | 2000 Sep |
2 |
| 13 | 11045671 | Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. | Acta Neuropathol | 2000 Nov |
1 |
| 14 | 11264780 | Dialysis-related amyloidosis: pathogenesis focusing on AGE modification. | Semin Dial | 2001 Mar-Apr |
2 |
| 15 | 11287350 | Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Am J Physiol Endocrinol Metab | 2001 May |
1 |
| 16 | 11304045 | Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation. | Neuropathology | 2001 Mar |
1 |
| 17 | 11576932 | Advanced glycation end products and the progressive course of renal disease. | Am J Kidney Dis | 2001 Oct |
1 |
| 18 | 11700025 | RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. | Biochem Biophys Res Commun | 2001 Nov 16 |
2 |
| 19 | 11854121 | Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. | Circulation | 2002 Feb 19 |
2 |
| 20 | 11978653 | Advanced glycation end product precursors impair epidermal growth factor receptor signaling. | Diabetes | 2002 May |
4 |
| 21 | 12239236 | Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. | J Am Soc Nephrol | 2002 Oct |
1 |
| 22 | 12406185 | Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain. | Pathol Int | 2002 Sep |
1 |
| 23 | 12446618 | Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. | Endocrinology | 2002 Dec |
1 |
| 24 | 12504085 | RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. | Biochem Biophys Res Commun | 2003 Jan 10 |
2 |
| 25 | 12663138 | Two polyclonal antisera detect different AGE epitopes in human plasma samples. | Immunol Lett | 2003 Feb 3 |
1 |
| 26 | 12765963 | A role for advanced glycation end products in diminished bone healing in type 1 diabetes. | Diabetes | 2003 Jun |
2 |
| 27 | 12829653 | Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. | Diabetes | 2003 Jul |
1 |
| 28 | 14679299 | Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. | Physiol Genomics | 2003 Dec 16 |
1 |
| 29 | 15340223 | N(epsilon)-(carboxymethyl)lysine proliferated CD34(+) cells from rat choroidal explant in culture. | Biol Pharm Bull | 2004 Sep |
1 |
| 30 | 15663474 | Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. | J Neurochem | 2005 Jan |
1 |
| 31 | 15684477 | Inhibitory effect of nifedipine on tumor necrosis factor alpha-induced neovascularization in cultured choroidal explants of streptozotocin-diabetic rat. | Biol Pharm Bull | 2005 Feb |
1 |
| 32 | 16263740 | Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. | Nephrol Dial Transplant | 2006 Feb |
1 |
| 33 | 16365515 | Transgenic mice over-expressing dicarbonyl/L-xylulose reductase gene crossed with KK-Ay diabetic model mice: an animal model for the metabolism of renal carbonyl compounds. | Exp Anim | 2005 Oct |
1 |
| 34 | 16374460 | The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. | J Invest Dermatol | 2006 Feb |
2 |
| 35 | 17347584 | Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. | Nephron Exp Nephrol | 2007 |
2 |
| 36 | 17504976 | Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. | FASEB J | 2007 Oct |
1 |
| 37 | 17567584 | Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. | J Biol Chem | 2007 Aug 10 |
2 |
| 38 | 18420491 | RAGE and modulation of ischemic injury in the diabetic myocardium. | Diabetes | 2008 Jul |
1 |
| 39 | 18434751 | Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension. | Nephron Clin Pract | 2008 |
1 |
| 40 | 18473845 | Role of advanced glycation end products in diabetic neuropathy. | Curr Pharm Des | 2008 |
1 |
| 41 | 19127169 | Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes. | J Investig Med | 2009 Feb |
2 |
| 42 | 19288028 | Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. | Int J Mol Med | 2009 Apr |
2 |
| 43 | 19334049 | Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. | J Pathol | 2009 Jul |
1 |
| 44 | 19397970 | Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats. | J Ethnopharmacol | 2009 Jul 15 |
2 |
| 45 | 19739013 | Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products. | J Immunoassay Immunochem | 2009 |
1 |
| 46 | 19811526 | High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis. | Eur J Clin Invest | 2009 Dec |
1 |
| 47 | 19962413 | Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction. | Peptides | 2010 Feb |
1 |
| 48 | 20067962 | Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. | Diabetes Care | 2010 Apr |
2 |
| 49 | 20157260 | Effects of increased iron intake during the neonatal period on the brain of adult AbetaPP/PS1 transgenic mice. | J Alzheimers Dis | 2010 |
2 |
| 50 | 20649531 | Glycoxidative stress-induced mitophagy modulates mitochondrial fates. | Ann N Y Acad Sci | 2010 Jul |
2 |